Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma

被引:0
|
作者
Barbara Heidenreich
Eduardo Nagore
P. Sivaramakrishna Rachakonda
Zaida Garcia-Casado
Celia Requena
Victor Traves
Jürgen Becker
Nadem Soufir
Kari Hemminki
Rajiv Kumar
机构
[1] German Cancer Research Center,Division of Molecular Genetic Epidemiology
[2] Instituto Valenciano de Oncologia,Department of Dermatology
[3] Universidad Catolica de Valencia,Department of Pathology
[4] Laboratory of Molecular Biology,Department of General Dermatology
[5] Instituto Valenciano de Oncologia,undefined
[6] Instituto Valenciano de Oncologia,undefined
[7] Medical University of Graz,undefined
[8] Departement de Genetique,undefined
[9] Hôpital Bichat-Claude Bernard,undefined
[10] APHP,undefined
[11] Center for Primary Health Care Research,undefined
[12] Lund University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We previously reported a disease segregating causal germline mutation in a melanoma family and recurrent somatic mutations in metastasized tumours from unrelated patients in the core promoter region of the telomerase reverse transcriptase (TERT) gene. Here we show that the TERT promoter mutations, besides causing an increased gene expression, associate with increased patient age, increased Breslow thickness and tumour ulceration in 287 primary melanomas. The mutations are more frequent at both intermittently and chronically sun-exposed sites than non-exposed sites and tend to co-occur with BRAF and CDKN2A alterations. The association with parameters generally connected with poor outcome, coupled with high recurrence and mechanistic relevance, raises the possibility of the eventual use of TERT promoter mutations in the disease management.
引用
收藏
相关论文
共 50 条
  • [41] Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review
    Yuan, Xiaotian
    Liu, Tiantian
    Xu, Dawei
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (19)
  • [42] TELOMERASE REVERSE TRANSCRIPTASE MUTATIONS ARE ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN NASH
    Donati, B.
    Vanni, E.
    Dongiovanni, P.
    Iavarone, M.
    Rametta, R.
    Rosso, C.
    Carnelutti, A.
    Petta, S.
    Fracanzani, A. L.
    Reeves, H. L.
    Dofour, J. F.
    Miele, L.
    Anstee, Q.
    Bugianesi, E.
    Soardo, G.
    Fargion, S.
    Valenti, L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S226 - S226
  • [43] Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia
    Yamaguchi, H
    Calado, RT
    Ly, H
    Kajigaya, S
    Baerlocher, GM
    Chanock, SJ
    Lansdorp, PM
    Young, NS
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14): : 1413 - 1424
  • [44] Mutations in the Telomerase Reverse Transcriptase Gene Predisposes to Myelodysplastic Syndromes
    Calado, Rodricio T.
    Prince, Courtney
    Peterson, Nathan R.
    Young, Neal S.
    Maciejewski, Jaroslaw P.
    BLOOD, 2009, 114 (22) : 172 - 173
  • [45] Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases
    Yang, Shi
    Leone, Dominick
    Frydenlund, Noah
    Hoang, Mai
    Deng, April
    Hernandez-Perez, Marier
    Biswas, Asok
    Singh, Rajendra
    Yaar, Ron
    Mahalingam, Meera
    MELANOMA RESEARCH, 2016, 26 (04) : 361 - 366
  • [46] Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia
    Papathomas, Thomas G.
    Oudijk, Lindsey
    Zwarthoff, Ellen C.
    Post, Edward
    Duijkers, Floor A.
    van Noesel, Max M.
    Hofland, Leo J.
    Pollard, Patrick J.
    Maher, Eamonn R.
    Restuccia, David F.
    Feelders, Richard A.
    Franssen, Gaston J. H.
    Timmers, Henri J.
    Sleijfer, Stefan
    de Herder, Wouter W.
    de Krijger, Ronald R.
    Dinjens, Winand N. M.
    Korpershoek, Esther
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : 653 - 661
  • [47] Telomerase Reverse Transcriptase (TERT) promoter mutational analysis of anorectal melanomas
    Yang, H. -M.
    Hsiao, S. J.
    Varma, H.
    Schaeffer, D. F.
    Horst, D.
    Mansukhani, M.
    Horst, B. A.
    VIRCHOWS ARCHIV, 2016, 469 : S166 - S167
  • [48] Characterizing telomerase reverse transcriptase (TERT) promoter mutations (mut) across sex, race, and cancer types.
    El Zarif, Talal
    Machaalani, Marc
    Nawfal, Rashad
    Xie, Wanling
    Choueiri, Toni K.
    Pomerantz, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
    Pirker, Christine
    Bilecz, Agnes
    Grusch, Michael
    Mohr, Thomas
    Heidenreich, Barbara
    Laszlo, Viktoria
    Stockhammer, Paul
    Loetsch-Gojo, Daniela
    Gojo, Johannes
    Gabler, Lisa
    Spiegl-Kreinecker, Sabine
    Dome, Balazs
    Steindl, Ariane
    Klikovits, Thomas
    Hoda, Mir Alireza
    Jakopovic, Marko
    Samarzija, Miroslav
    Mohorcic, Katja
    Kern, Izidor
    Kiesel, Barbara
    Brcic, Luka
    Oberndorfer, Felicitas
    Muellauer, Leonhard
    Klepetko, Walter
    Schmidt, Wolfgang M.
    Kumar, Rajiv
    Hegedus, Balazs
    Berger, Walter
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3819 - 3830
  • [50] Telomerase Reverse Transcriptase Gene Promoter Mutations Help Discern the Origin of Urogenital Tumors: A Genomic and Molecular Study
    Wu, Song
    Huang, Peide
    Li, Chong
    Huang, Yi
    Li, Xianxin
    Wang, Yongqiang
    Chen, Chao
    Lv, Zhaojie
    Tang, Aifa
    Sun, Xiaojuan
    Lu, Jingxiao
    Li, Weiping
    Zhou, Jie
    Gui, Yaoting
    Zhou, Fangjian
    Wang, Daping
    Cai, Zhiming
    EUROPEAN UROLOGY, 2014, 65 (02) : 274 - 277